The M&A Performance Study Of China Meheco Group Co Ltd Merging Henan Topfond Pharmaceutical

In condition of the economic globalization and intense competition environment,enhancing a firm's competitive advantage become more and more important.There are two main ways to do so,one is through technology innovation and creation the other is optimize resources and expand externally.Most of the firms would choose the second method,which is mergers and acquisitions.With China's rapid growth and aged tendency of population,the new medical reform policy;even if the scale of medical consumer market continues to expand and China's become one of the world's fastest growing region of drug computation,the inferior R&D capability,the low concentration degree of production,and the homogenization of product has limits the development of China's pharmaceutical industry.In order to promote the healthy development of the industry,the government of China has promulgated a series of policies to promote the reform of China's medical system,and also inject a large amount of fund.Therefore,mergers and acquisitions has become the preferred way to promote the healthy and sustainable development of the pharmaceutical industry.This paper take China Meheco Group Co Ltd Merging Henan Topfond pharmaceutical case to analysis: the first part introduces research background,research significance,research methods,research content,and framework;the second part introduces the principle,motivation,performance and other related theories of acquisition.As the theoretical support for the paper;the third part introduces the main parties and motivation of merger and acquisition;the fourth part is the The M & A Performance Study of China Meheco Group Co Ltd Merging Henan Topfond pharmaceutical,first I use the event study strategy to analyze the acquisition performance,and then use the index analysis on merger financial performance index,finally I select some easy to measure indexes of the China medicine's non-financial performance to better analysis.The fifth part is the problems and suggestions,through the comprehensive analysis above,I found the problems in mergers and acquisitions of pharmaceutical industry,and put forward corresponding suggestions to improve the performance of mergers and acquisitions according to the problem,hoping to provide reference for mergers and acquisitions in the pharmaceutical industry.